KR20040020054A - 통증 치료시 중독 예방 - Google Patents

통증 치료시 중독 예방 Download PDF

Info

Publication number
KR20040020054A
KR20040020054A KR10-2003-7014736A KR20037014736A KR20040020054A KR 20040020054 A KR20040020054 A KR 20040020054A KR 20037014736 A KR20037014736 A KR 20037014736A KR 20040020054 A KR20040020054 A KR 20040020054A
Authority
KR
South Korea
Prior art keywords
gaba
day
analgesic
administered
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR10-2003-7014736A
Other languages
English (en)
Korean (ko)
Inventor
스테판 엘. 듀이
조나단 디. 부로디
찰스 알. 주니어 애쉬비
Original Assignee
브룩하벤 싸이언스 어쏘씨에이츠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 브룩하벤 싸이언스 어쏘씨에이츠 filed Critical 브룩하벤 싸이언스 어쏘씨에이츠
Publication of KR20040020054A publication Critical patent/KR20040020054A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR10-2003-7014736A 2001-05-14 2002-04-08 통증 치료시 중독 예방 Withdrawn KR20040020054A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/853,548 US20020187996A1 (en) 2001-05-14 2001-05-14 Prevention of addiction in pain management
US09/853,548 2001-05-14
PCT/US2002/011072 WO2002091990A2 (en) 2001-05-14 2002-04-08 Prevention of addiction in pain management

Publications (1)

Publication Number Publication Date
KR20040020054A true KR20040020054A (ko) 2004-03-06

Family

ID=25316324

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2003-7014736A Withdrawn KR20040020054A (ko) 2001-05-14 2002-04-08 통증 치료시 중독 예방

Country Status (21)

Country Link
US (3) US20020187996A1 (enExample)
EP (1) EP1392301B1 (enExample)
JP (1) JP2004534029A (enExample)
KR (1) KR20040020054A (enExample)
CN (1) CN100528156C (enExample)
AT (1) ATE473001T1 (enExample)
AU (1) AU2002342533B2 (enExample)
BR (1) BR0209613A (enExample)
CA (1) CA2446639C (enExample)
CZ (1) CZ20033380A3 (enExample)
DE (1) DE60236927D1 (enExample)
ES (1) ES2348637T3 (enExample)
HR (1) HRP20030892A2 (enExample)
HU (1) HUP0402326A3 (enExample)
IL (1) IL158762A0 (enExample)
MX (1) MXPA03010407A (enExample)
NO (1) NO331509B1 (enExample)
NZ (1) NZ529614A (enExample)
PL (1) PL368505A1 (enExample)
WO (1) WO2002091990A2 (enExample)
YU (1) YU89003A (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080053423A (ko) * 2000-07-31 2008-06-12 니코메드 댄마크 에이에스 코 투여용 펜타닐 조성물
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US20050043345A1 (en) * 2003-08-22 2005-02-24 Pfizer Inc Pharmaceutical composition for the prevention and treatment of addiction in a mammal
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
CN105497896A (zh) * 2015-03-31 2016-04-20 苏州大学 一种肿瘤耐药的靶点及其应用
EP4230199A4 (en) 2020-12-04 2024-07-31 Laboratorios Silanes, S.A. de C.V. COATED AND STABLE SOLID PHARMACEUTICAL COMPOSITION OF AN ANALGESIC AND AN ANTIEPILEPTIC AGAINST PAIN
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057368A (en) * 1998-08-05 2000-05-02 Brookhaven Science Associates Llc Treatment of addiction and addiction-related behavior
US6541520B1 (en) * 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior

Also Published As

Publication number Publication date
US20030004176A1 (en) 2003-01-02
HRP20030892A2 (en) 2005-08-31
EP1392301A4 (en) 2004-07-14
MXPA03010407A (es) 2004-05-05
NZ529614A (en) 2006-08-31
CA2446639C (en) 2010-11-02
CN1531431A (zh) 2004-09-22
HUP0402326A3 (en) 2008-04-28
EP1392301B1 (en) 2010-07-07
JP2004534029A (ja) 2004-11-11
CA2446639A1 (en) 2002-11-21
ATE473001T1 (de) 2010-07-15
CZ20033380A3 (cs) 2005-03-16
AU2002342533B2 (en) 2007-07-05
US20020187996A1 (en) 2002-12-12
YU89003A (sh) 2006-08-17
EP1392301A2 (en) 2004-03-03
DE60236927D1 (de) 2010-08-19
ES2348637T3 (es) 2010-12-10
US20030134868A1 (en) 2003-07-17
WO2002091990A3 (en) 2003-03-27
CN100528156C (zh) 2009-08-19
BR0209613A (pt) 2004-12-07
HUP0402326A2 (hu) 2005-02-28
PL368505A1 (en) 2005-04-04
NO331509B1 (no) 2012-01-16
WO2002091990A2 (en) 2002-11-21
NO20035038D0 (no) 2003-11-13
US6939876B2 (en) 2005-09-06
IL158762A0 (en) 2004-05-12

Similar Documents

Publication Publication Date Title
JP2001527554A (ja) 抗うつ薬とｎｍｄａレセプター拮抗薬とを組み合わせる神経障害痛の治療用組成物及び治療方法
JP2017506244A (ja) ノルイボガイン及び関連化合物を用いた治療方法
KR20040020054A (ko) 통증 치료시 중독 예방
KR20220113411A (ko) KV7 칼륨 채널 개방제(opener)의 통증 치료를 위한 용도
AU2016302769A1 (en) Antitussive compositions and methods
AU2002342533A1 (en) Prevention of addiction in pain management
JPH045231A (ja) 慢性痛用鎮痛剤
CA1141664A (en) Analgesic composition
US10736874B1 (en) Methods for treating pain associated with sickle cell disease
RU2823100C2 (ru) Анальгетическая субстанция эндогенной природы, фармацевтическая композиция на ее основе и способы их применения
AU2025271432A1 (en) CGRP antagonists for the treatment of medication overuse headache, post-traumatic headache, post-concussion syndrome and vertigo
RU2213561C2 (ru) Болеутоляющие композиции, содержащие ненаркотический анальгетик и усилитель анальгезии
JP2009510158A (ja) 毒物依存症の治療におけるネボグラミンの使用
WO2025198489A1 (ru) Анальгетическая субстанция эндогенной природы, фармацевтическая композиция на ее основе и способы их применения
EP0966286B1 (en) Attenuation of opioid tolerance by inhibiting inducible nitric oxide synthase pathways in the treatment of pain
US20090281194A1 (en) Combinations for treating HIV-associated pain
EP3801545A1 (en) Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof
CA2521741A1 (en) Pharmaceutical composition comprising a cathepsin s inhibitor and an opioid

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20031113

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid